[1]
Barbosa, D.B. 2019. Prior approval by ANVISA: only to protect public health? The Journal of Intellectual Property – Contemporary Law and Constitution. 8, 5 (Dec. 2019), 298–355. DOI:https://doi.org/10.16928/2316-8080.V12N3p.298-355.